Clari Vest Asset Management LLC Celldex Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $790,993 - $999,643	-26,114 Reduced 43.52%	33,894 $1.15 Million
Q1 2023 May 08, 2023	SELL	$34.78 - $47.43 $428,767 - $584,717	-12,328 Reduced 17.04%	60,008 $2.16 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $16,195 - $26,456	-583 Reduced 0.8%	72,336 $3.22 Million
Q3 2022 Nov 10, 2022	BUY	$22.7 - $37.57 $1.28 Million - $2.12 Million	56,519 Added 344.63%	72,919 $2.05 Million
Q1 2022 May 04, 2022	SELL	$27.64 - $39.32 $63,572 - $90,436	-2,300 Reduced 12.3%	16,400 $559,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $520,928 - $821,542	-14,600 Reduced 43.84%	18,700 $722,000
Q3 2021 Nov 08, 2021	SELL	$28.95 - $55.99 $5,790 - $11,198	-200 Reduced 0.6%	33,300 $1.8 Million
Q2 2021 Aug 09, 2021	BUY	$20.71 - $35.37 $693,785 - $1.18 Million	33,500 New	33,500 $1.12 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.